SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-15-009429
Filing Date
2015-12-11
Accepted
2015-12-11 14:49:35
Documents
1
Group Members
GEMINI STRATEGIES LLC, INC.STEVEN WINTERS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g1215gemini_oxysure.htm SC 13G 96070
  Complete submission text file 0001213900-15-009429.txt   97800
Mailing Address GEMINI STRATEGIES LLC 619 SO. VULCAN AVE. SUITE #203 ENCINITAS CA 92024
Business Address GEMINI STRATEGIES LLC 619 SO. VULCAN AVE. SUITE #203 ENCINITAS CA 92024 858 480 2828
GEMINI MASTER FUND LTD (Filed by) CIK: 0001403092 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034
Business Address 10880 JOHN W. ELLIOTT ROAD SUITE 600 Frisco TX 75034 (972) 294-6450
OxySure Therapeutics, Inc. (Subject) CIK: 0001413797 (see all company filings)

IRS No.: 710960725 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88004 | Film No.: 151283029
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10